Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Consumer Services, Utilities and Basic Materials sectors led shares higher. At the close in...
Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Technology, Healthcare and Consumer Services sectors led shares higher. At the close in NYSE,...
Investing.com – U.S. stocks were lower after the close on Tuesday, as losses in the Basic Materials, Industrials and Oil & Gas sectors led shares lower. At the close in NYSE, the...
Cigna Corporation (NYSE:CI) CI is set to report first-quarter 2021 results on May 7, before the opening bell.In the fourth quarter of 2020, the company’s earnings of $3.51...
Adamas Pharmaceuticals (NASDAQ:ADMS) ADMS shares rallied 5.9% in the last trading session to close at $5.03. This move can be attributable to notable volume with a higher number of...
Humana Inc.’s (NYSE:HUM) third-quarter 2019 results are scheduled to be reported on Nov 6, 2019.The Zacks Consensus Estimate for earnings is pegged at $4.58, indicating no...
Adamas Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company. The Company is engaged in drug discovery, development and commercialization to deliver medicines for patients, caregivers, and society. The Company’s portfolio product GOCOVRI (amantadine) extended release capsules is used for the treatment of dyskinesia in patients with Parkinson’s disease. Its OSMOLEX ER (amantadine) extended-release tablets is used for the treatment for Parkinson’s disease and drug-induced extrapyramidal reactions in adult patients. Its ADS-5102 is in development for the treatment of walking impairment in patients with multiple sclerosis (MSW). Its product candidate ADS-4101 (lacosamide) modified release capsules is in development for the treatment of partial onset seizures in patients with epilepsy. Its Namzaric (memantine hydrochloride extended release and donepezil hydrochloride) capsules are used for the treatment of dementia of an Alzheimer’s type.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | |||||
| Technical Indicators | |||||
| Summary |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 138.23 | 141.11 | 137.91 | -4.07 | -2.86% | 46.92M | NASDAQ | |||
| 49.15 | 49.44 | 48.73 | +0.57 | +1.17% | 15.25M | NYSE | |||
| 463.95 | 470.76 | 459.77 | -13.81 | -2.89% | 1.50M | NASDAQ | |||
| 11.03 | 12.55 | 10.26 | -7.52 | -40.54% | 132.61M | NASDAQ | |||
| 89.63 | 91.65 | 89.18 | -1.11 | -1.22% | 10.81M | NYSE | |||
| 18.70 | 18.98 | 18.07 | +0.14 | +0.75% | 21.88K | NASDAQ | |||
| 266.54 | 267.75 | 265.54 | -0.04 | -0.01% | 1.76M | NYSE | |||
| 1.80 | 1.918 | 1.78 | -0.090 | -4.76% | 1.08M | NASDAQ | |||
| 0.97 | 0.995 | 0.948 | +0.030 | +3.17% | 6.34K | NASDAQ | |||
| 1.66 | 1.87 | 1.51 | -0.21 | -11.23% | 352.60K | NASDAQ | |||
| 183.77 | 185.44 | 181.58 | -4.16 | -2.21% | 4.24M | NYSE | |||
| 7.57 | 8.06 | 7.54 | -0.59 | -7.23% | 1.11M | NASDAQ | |||
| 5.14 | 5.219 | 5.14 | -0.070 | -1.34% | 47.26K | NYSE | |||
| 71.29 | 72.49 | 63.84 | +6.41 | +9.88% | 79.50M | NYSE | |||
| 713.85 | 737.25 | 712.31 | -31.37 | -4.21% | 770.23K | NYSE |